Synchneuro

Seed
synchneuro.com Biotech & Healthcare United States
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Nov 12, 2025
Investors 1 Backer
Decision Makers 2 Verified

About Synchneuro

Synchneuro develops EEG-guided neuromodulation devices and software for synchronized TMS therapies and clinical support.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters United States
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website synchneuro.com
Domain Registered Date Jun 6, 2021

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Seed announced

    fundraisingfox.com

  2. Milestone

    Website domain registered

    synchneuro.com

Investors & Backers

1
Plug and Play

Funding History

2 Rounds
Seed · Nov 12, 2025
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

3

Casey Halpern

Founder & Chairman

Work email & phone locked Unlock →

Emily Mirro

President & Co-Founder

Work email & phone locked Unlock →

Heonsoo Lee

CSO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts